Skip to main content
Premium Trial:

Request an Annual Quote

Pharmacopeia s Revenues Drop Sharply in Q1; Spin-off to Close this Month

This update serves to correct that Pharmacopeia reported a sharp decrease in first-quarter revenues. An earlier version incorrectly reported in the first paragraph that there was a sharp increase in revenue. The article also should have mentioned that Pharmacopeia said in December last year it would change its name to Accelrys.

 

NEW YORK, April 8 (GenomeWeb News) - Pharmacopeia reported a sharp increase in revenues for the first quarter yesterday. The company also said that it expects to finalize the spin-off of its Pharmacopeia Drug Discovery unit by the end of the month, at which time it will change its name to Accelrys. The spin-off and name-change were originally supposed to take place at the end of last month.

 

Pharmacopeia's consolidated revenues fell by a third during the first quarter of 2004, compared to the same quarter a year ago. The company has not yet stated its revenues formally.

 

Pending on shareholder approval, Pharmacopeia will trade under the symbol "ACCL" after the spin-off is completed. Pharmacopeia Drug Discovery's common stock will trade under the symbol "PCOP", subject to Nasdaq approval. The spin-off, first announced last year, is subject to regulatory approval and other conditions.

 

As of the end of March, Pharmacopeia had $141 million in cash and cash equivalents, $7 million more than at the end of last year.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.